Modern approach in the therapy of Alzheimer's disease
Alzheimer's disease is a well-known neurodegenerative disorder. One of its main risk factors is age. Due to a worldwide increase of human longevity Alzheimer's disease became the most common form of dementia. The disease has been studied in different countries for many decades but still it...
Main Authors: | D. I. Rodin, A. L. Schvarzman, S. V. Saranzeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Academician I.P. Pavlov First St. Petersburg State Medical University
2014-03-01
|
Series: | Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова |
Subjects: | |
Online Access: | https://www.sci-notes.ru/jour/article/view/5 |
Similar Items
-
Amyloid-beta 40 as a biomarker of cognitive impairment in acute ischemic stroke
by: Aleksey A. Kulesh, et al.
Published: (2017-10-01) -
Прижизненная оценка накопления β-амилоида в головном мозге человека
by: А. Г. Власенко, et al.
Published: (2017-02-01) -
Changes in the activity of lysosomal cysteine proteases of plasma mononuclear and polymorphonuclear blood leukocytes in Alzheimer’s disease
by: M. G. Sorokina, et al.
Published: (2020-10-01) -
Alzheimer's disease: from theory to practice
by: А. S. Kotov, et al.
Published: (2015-12-01) -
Alzheimer’s disease with an early debut
by: N. N. Koberskaya, et al.
Published: (2019-03-01)